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ABSTRACT 
 
 The last decade has seen an outgrowth in the development of synthetic 
methodologies exploiting benzyne.  The unique ability of this reactive intermediate to 
directly furnish ortho-difuntionalized aromatic systems first stoked interest in this 
research group as a possible partner in asymmetric arylation reactions.  Since our initial 
forays, we have expanded our synthetic strategies to include bond insertions, 
cycloadditions, condensations, and multicomponent reactions. 
 The first project discussed in this volume is the development of an aryne 
annulation strategy for constructing common, synthetically useful heterocyclic structures 
in a convergent manner.  We have developed a convergent approach to indoles and 
indolines.  Likewise, through an orthogonal functional group intallation upon an enamine 
substrate, isoquinolines, quinolines, and isoquinolones can all be accessed as well.  In this 
manner, we have been able to generate an array of functionalized heterocycles, including 
some that are prohibited by traditional means of synthesis.  We have also begun to 
understand some of the reactivity trends in this context for the elusive aryne reaction 
partner. 
 The development of the aryne annulation strategy for the synthesis of 
isoquinolines directly led to the shortest reported total synthesis of the opiate alkaloid 
papaverine, and the tetrahydroisoquinoline anticancer antibiotic quinocarcin.  Our more 
recent, ongoing efforts toward the synthesis of the bis-tetrahydroisoquinoline antitumor 
molecule jorumycin and its many structural relatives are detailed herein.  Jorumycin has 
been targeted through a combination of aryne annulation and acyl-
alkylation/condensation methodologies aimed at the synthesis of a functionalized bis-
isoquinoline intermediate.  Reduction of this key bis-isoquinoline to a bis-
tetrahydroisoquinoline and subsequent lactamization will provide the pentacyclic core of 
jorumycin and related natural products in only three steps from simple isoquinoline 
building blocks. 
 The final project described is the development of several different aryne 
multicomponent reactions to form novel carbo- and heterocyclic scaffolds, including 
iminoisobenzfurans, iminoindenones, dibenzoketocaprolactams, and 2-quinolones. 
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